Marc Whitman
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- Antimicrobial Resistance in Staphylococcus 3
- Tuberculosis Research and Epidemiology 1
-
- Pneumonia and Respiratory Infections 2
- Pneumocystis jirovecii pneumonia detection and treatment 1
- Infective Endocarditis Diagnosis and Management 1
- Co-authors
- Allan R. Tunkel (2 shared papers)W. Michael Scheld (1 shared paper)Amy J. Osborne (2 shared papers)Christine Cole Johnson (2 shared papers)P. G. Pitsakis (2 shared papers)Matthew E. Levison (2 shared papers)A. Lee Osterman (1 shared paper)Lawrence L. Livornese (1 shared paper)
- Journals
- Infection Control and Hospital Epidemiology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of Medical Virology (1 paper)Hand Clinics (1 paper)American Journal of Health-System Pharmacy (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
Marc Whitman
8 papers receiving 257 citations
Peers
Comparison fields: 5 of 68
- Molecular Medicine 57
- Infectious Diseases 117
- Clinical Biochemistry 42
- Microbiology 30
- Pharmacology 73
Countries citing papers authored by Marc Whitman
This map shows the geographic impact of Marc Whitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Whitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Whitman more than expected).
Fields of papers citing papers by Marc Whitman
This network shows the impact of papers produced by Marc Whitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Whitman. The network helps show where Marc Whitman may publish in the future.
Co-authors
The 10 scholars most cited alongside Marc Whitman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 84 | |
| 2 | 1992 | 54 | |
| 3 | 1993 | 39 | |
| 4 | 1996 | 37 | |
| 5 | 2018 | 26 | |
| 6 | 2002 | 23 | |
| 7 | 2021 | 12 | |
| 8 | 2021 | 4 |
About Marc Whitman
Marc Whitman is a scholar working on Infectious Diseases, Epidemiology, Surgery, Pharmacology and Cellular and Molecular Neuroscience, having authored 8 papers that have together received 279 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Pneumonia and Respiratory Infections (2 papers), Nerve Injury and Rehabilitation (1 paper), Orthopedic Surgery and Rehabilitation (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Infective Endocarditis Diagnosis and Management (1 paper) and Tuberculosis Research and Epidemiology (1 paper). The work is most often cited by research in Molecular Medicine (57 citations), Infectious Diseases (117 citations), Clinical Biochemistry (42 citations), Microbiology (30 citations) and Pharmacology (73 citations). Marc Whitman has collaborated with scholars based in United States and India. Frequent co-authors include Allan R. Tunkel, W. Michael Scheld, Amy J. Osborne, Christine Cole Johnson, P. G. Pitsakis, Matthew E. Levison, A. Lee Osterman, Lawrence L. Livornese, E DeJesus and Muhammet Özer. Their work appears in journals such as Infection Control and Hospital Epidemiology, Antimicrobial Agents and Chemotherapy, Journal of Medical Virology, Hand Clinics and American Journal of Health-System Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.